Metabolism of eicosapentaenoic and docosahexaenoic acids by recombinant human cytochromes P450.
about
15-lipoxygenase metabolites of docosahexaenoic acid inhibit prostate cancer cell proliferation and survivalSoluble epoxide hydrolase inhibition, epoxygenated fatty acids and nociceptionAdvances in Our Understanding of Oxylipins Derived from Dietary PUFAsDietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathwayCytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolismInhibition of soluble epoxide hydrolase attenuates high-fat-diet-induced hepatic steatosis by reduced systemic inflammatory status in miceThe role of AHR-inducible cytochrome P450s in metabolism of polyunsaturated fatty acidsModulation of blood oxylipin levels by long-chain omega-3 fatty acid supplementation in hyper- and normolipidemic menThe development of a specific and sensitive LC-MS-based method for the detection and quantification of hydroperoxy- and hydroxydocosahexaenoic acids as a tool for lipidomic analysisCytochrome P450-generated metabolites derived from ω-3 fatty acids attenuate neovascularizationCytochrome P450 2C epoxygenases mediate photochemical stress-induced death of photoreceptors.Decreased hippocampal volume and increased anxiety in a transgenic mouse model expressing the human CYP2C19 gene.Treatment of mice with 2,3,7,8-Tetrachlorodibenzo-p-dioxin markedly increases the levels of a number of cytochrome P450 metabolites of omega-3 polyunsaturated fatty acids in the liver and lung.An omega-3 epoxide of docosahexaenoic acid lowers blood pressure in angiotensin-II-dependent hypertension.Naturally occurring monoepoxides of eicosapentaenoic acid and docosahexaenoic acid are bioactive antihyperalgesic lipids.Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance.Dietary Omega-3 Polyunsaturated Fatty Acids Prevent Vascular Dysfunction and Attenuate Cytochrome P4501A1 Expression by 2,3,7,8-Tetrachlorodibenzo-P-Dioxin.Role of CYP1A1 in modulating the vascular and blood pressure benefits of omega-3 polyunsaturated fatty acidsAnalgesia mediated by soluble epoxide hydrolase inhibitors is dependent on cAMP.Activation of vascular BK channels by docosahexaenoic acid is dependent on cytochrome P450 epoxygenase activityStereoselective epoxidation of the last double bond of polyunsaturated fatty acids by human cytochromes P450.Caenorhabditis Elegans Mutants Predict Regulation of Fatty Acids and Endocannabinoids by the CYP-35A Gene Family.Effects of acetylenic epoxygenase inhibitors on recombinant cytochrome p450s2,3,7,8-Tetrachlorodibenzo-p-dioxin treatment alters eicosanoid levels in several organs of the mouse in an aryl hydrocarbon receptor-dependent fashionElucidation of functions of human cytochrome P450 enzymes: identification of endogenous substrates in tissue extracts using metabolomic and isotopic labeling approachesTranscriptome-based identification of antioxidative gene expression after fish oil supplementation in normo- and dyslipidemic men.Elevated blood pressure in cytochrome P4501A1 knockout mice is associated with reduced vasodilation to omega-3 polyunsaturated fatty acidsMetabolism of arachidonic acid by the cytochrome P450 enzyme in patients with chronic Keshan disease and dilated cardiomyopathy.Eicosanoids in metabolic syndrome.Dangerous combinations: Ingestible CAM supplement use during chemotherapy in patients with ovarian cancer.The Use of Complementary and Alternative Medicine Supplements of Potential Concern during Breast Cancer Chemotherapy.Endogenous functions of the aryl hydrocarbon receptor (AHR): intersection of cytochrome P450 1 (CYP1)-metabolized eicosanoids and AHR biology.Epoxyeicosatrienoic acids: formation, metabolism and potential role in tissue physiology and pathophysiology.The cytochrome P450 pathway in angiogenesis and endothelial cell biology.Role of cytochrome P450-mediated arachidonic acid metabolites in the pathogenesis of cardiac hypertrophy.17(R),18(S)-epoxyeicosatetraenoic acid, a potent eicosapentaenoic acid (EPA) derived regulator of cardiomyocyte contraction: structure-activity relationships and stable analogues.14,15-Epoxyeicosa-5,8,11-trienoic acid (14,15-EET) surrogates containing epoxide bioisosteres: influence upon vascular relaxation and soluble epoxide hydrolase inhibition.Asymmetric Binding and Metabolism of Polyunsaturated Fatty Acids (PUFAs) by CYP2J2 Epoxygenase.Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of {omega}-3 fatty acids3,3',4,4',5-Pentachlorobiphenyl (PCB 126) Decreases Hepatic and Systemic Ratios of Epoxide to Diol Metabolites of Unsaturated Fatty Acids in Male Rats.
P2860
Q21134042-4334955B-86E0-445D-9CF5-265EFF4222CDQ24628660-22040FDC-99F7-4EA1-9FEA-D762B6B5C9B4Q27014988-56662A76-816C-45A8-9E46-3FBA2293ADD2Q28235974-F5A12753-0301-4E1A-80E8-46E6F644765FQ28245279-F8D39C7D-A269-4473-A130-3DFBE90D9180Q28385478-86D5EB5B-FCBE-471C-985E-2D8F8B5C2A90Q28389473-F33D5D5D-A099-4058-9526-EAE7BC27956DQ28392212-36C8BADC-2D7F-437C-980F-85BA0983E79EQ28534679-CBEFFF7C-CA20-4EC2-B6F9-F05A90829485Q30583016-6111864A-E69F-49E2-AD48-1E6958BD6123Q31151454-24726F61-D230-4379-A7E8-9867E43A5286Q33652540-E556BFEE-01F7-4C99-BE5D-25AFB5A97535Q33798656-FD43D3EF-361B-4DAB-90A0-122ABC5CA842Q33882374-FA334F7D-EEC6-40F9-AA9F-C8ECC84268BBQ34287840-EDCED270-00D5-4AF3-824C-5CCC575E42DAQ34358307-F387627E-34AE-40B7-8216-1E26B46EF668Q34536466-A021BD44-87DE-4E30-82E5-3B622560E4ACQ34573870-E1D86227-7C7D-4D36-B0D1-80DFEC53344BQ34720827-9506B3BB-E862-426D-ADB5-1F9A17C8A99CQ34808479-3CC6A5AF-4F73-4E8E-B57E-0F0FD98C8940Q35016255-4BEF05ED-F6CD-45B9-8374-20A0877DC964Q35026072-CFCD063D-123E-4741-92A2-A6270FD19D1BQ35079537-C66EF5CB-9201-457A-9967-19BAE9F0693FQ35783207-BE61656C-E468-4358-8DE7-7FAEF9983548Q35968168-0DA6DE3F-FC51-46AA-93AC-7A472AF58A6AQ36127724-2090C671-BD29-4F7C-A48C-6035E19726B3Q36388072-5EC720C8-F8B0-4F08-A502-509E47103E5AQ36524657-FE87636F-35D9-4D9A-AF79-DC4347D69B42Q36911098-A9632E9E-7D28-42F4-9A1F-C41E48DC835EQ37064936-79818BFD-9AC6-4F09-8EFF-EAE2ACE3F3C9Q37159550-6C8B4071-4C0C-4661-8EB2-2A74949FD38EQ37247441-01BD29C0-AD28-4552-8432-0B0DD3086F1AQ37510865-C94B3B72-C4CC-4903-9A05-C80D3C069353Q37947082-0732F6D3-890B-459B-BE5E-F472D7F1E504Q38100223-356EB76F-3A7A-408A-9768-64F5E55C1C16Q39749097-28A8AA34-F7F8-48DA-9A4A-08BADD863484Q41202514-27E19E99-EC65-4962-855C-29A33031FC1EQ41429574-352EFC47-7336-4154-AC9A-E973E788D7A6Q42108073-663D8269-23B2-4542-B772-770C1209ADFDQ42404212-AA3DD5CD-09D2-48B7-B574-39BFF389FCBF
P2860
Metabolism of eicosapentaenoic and docosahexaenoic acids by recombinant human cytochromes P450.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Metabolism of eicosapentaenoic ...... binant human cytochromes P450.
@ast
Metabolism of eicosapentaenoic ...... binant human cytochromes P450.
@en
Metabolism of eicosapentaenoic ...... binant human cytochromes P450.
@nl
type
label
Metabolism of eicosapentaenoic ...... binant human cytochromes P450.
@ast
Metabolism of eicosapentaenoic ...... binant human cytochromes P450.
@en
Metabolism of eicosapentaenoic ...... binant human cytochromes P450.
@nl
prefLabel
Metabolism of eicosapentaenoic ...... binant human cytochromes P450.
@ast
Metabolism of eicosapentaenoic ...... binant human cytochromes P450.
@en
Metabolism of eicosapentaenoic ...... binant human cytochromes P450.
@nl
P2093
P1476
Metabolism of eicosapentaenoic ...... binant human cytochromes P450.
@en
P2093
Danièle Lucas
François Berthou
Jean-Pierre Salaün
Laurent Corcos
Yolande Amet
Yvonne Dréano
P304
P356
10.1016/J.ABB.2008.01.002
P407
P577
2008-01-11T00:00:00Z